Core Viewpoint - Accuray is undergoing a comprehensive transformation plan aimed at improving operational efficiency, accountability, and profitability, while facing challenges from geopolitical instability and tariff impacts, particularly in China. Financial Performance - Accuray reported a net revenue of $102.2 million for Q2, down 12% year-over-year, with product revenue falling to $45.0 million (down 26%) and service revenue increasing to $57.2 million (up 4%) [5][9][10] - The gross margin decreased to 23.5% from 36.1% a year ago, primarily due to a significant drop in product gross margin, which fell to 19.7% from 43.5% [5][12] - The company posted an operating loss of $11.6 million compared to an operating income of $4.7 million in the prior-year quarter, with adjusted EBITDA showing a loss of $1.9 million [13] Strategic Initiatives - The company is targeting an annualized operating profitability improvement of approximately $25 million, which includes a workforce reduction of about 15% and expects around $12 million of benefit in fiscal 2026 [2][5] - Accuray is focusing on expanding its service portfolio to create a "solutions-oriented" offering, enhancing uptime and driving higher-margin recurring revenue [7] - Initiatives include optimizing pricing, improving billing and collections, and building a structured distributor partnership program [6][7][8] Guidance and Outlook - The fiscal 2026 revenue guidance has been revised to $440 million to $450 million, with adjusted EBITDA expectations of $22 million to $25 million, reflecting ongoing volatility in China and tariff pressures [16][22] - Management aims for a high single-digit adjusted EBITDA margin run rate within nine months, with aspirations to reach double digits in the medium to long term [17] Market Dynamics - The decline in product revenue is attributed to geopolitical tensions and tariff impacts, particularly affecting the Chinese market [4][9][14] - Despite the challenges, discussions with customers indicate no significant downturn in hospital capital expenditure appetite [18] Balance Sheet - As of the end of the quarter, Accuray had $41.9 million in total cash and equivalents, down from $63.9 million in the previous quarter, primarily due to working capital usage and restructuring payments [19]

Q4'FY25 Earnings Call Supplemental Presentation August 13, 2025 Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this presentation relate, but are not limited, to: expectations regarding adjusted EBITDA and revenue; our ability to execute on our ...